Početna › Srpasto stanica › Texas › Houston
Kliničke studije za Srpasto stanica u gradu Houston, TX
10 studija za Srpasto stanica traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
U tijeku regrutacijaFaza 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
U tijeku regrutacijaFaza 3
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
U tijeku regrutacijaFaza 3
- UT Health University of Texas, Houston
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
- UT Health Science Center, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
U tijeku regrutacijaOpažajna studija
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
U tijeku regrutacijaFaza 3
- Baylor College of Medicine- Site Number : 8400055, Houston
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
U tijeku regrutacijaOpažajna studija
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
U tijeku regrutacijaFaza 3
- Site # 8400004, Houston
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
U tijeku regrutacijaFaza 2
- Baylor College of Medicine, Houston
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
U tijeku regrutacijaOpažajna studija
- University of Texas at Houston, Houston
Studije za Srpasto stanica u drugim gradovima
- Atlanta, GA22 studija
- Washington, DC20 studija
- Memphis, TN18 studija
- Chicago, IL18 studija
- Philadelphia, PA15 studija
- Birmingham, AL14 studija
- New York City, NY13 studija
- St. Louis, MO12 studija
- Durham, NC10 studija
- Cincinnati, OH10 studija
- Boston, MA10 studija
- Pittsburgh, PA9 studija
Ostale studije u gradu Houston
- Nemikrocelularni karcinom pluća145 studija
- Rak dojke126 studija
- Rak (sve vrste)121 studija
- Metastatski karcinom104 studija
- Kolorektalni rak102 studija
- Rak jajnika89 studija
- Akutna mijeloična leukemija85 studija
- Rak pluća78 studija
- Rak prostate76 studija
- Rak endometrija68 studija
- Rak gušterače61 studija
- Melanom59 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.